Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Rep. 2019 10 15; 29(3):573-588.e7.
View in:
PubMed
subject areas
Animals
Animals
Dimerization
Dimerization
Drug Resistance, Neoplasm
Drug Resistance, Neoplasm
Female
Female
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Intracellular Signaling Peptides and Proteins
Intracellular Signaling Peptides and Proteins
Melanoma
Melanoma
Mice
Mice
Mice, Nude
Mice, Nude
Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinases
Oncogene Proteins, Fusion
Oncogene Proteins, Fusion
Protein Isoforms
Protein Isoforms
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins B-raf
ras Proteins
ras Proteins
RNA Interference
RNA Interference
RNA, Small Interfering
RNA, Small Interfering
Signal Transduction
Signal Transduction
authors with profiles
Kevin Michael Brown